The collagen lattice: a model for studying the physiology, biosynthetic function and pharmacology of the skin

Until recently, changes in cell physiology following application of pharmacological agents have been studied in vivo or in vitro using monolayered cells. Although both approaches have unique advantages, both have shortcomings. Now the development of a skin-equivalent model has provided a system for studying cell responses at the tissue and organ levels in vitro (Bell, Ivarsson & Merrill, 1979; Bell et al., 1981a, b). The in vitro tissue model can be made simple or complex with respect to eel! type heterogeneity and matrix constitution; ideally, however, it should resemble skin as closely as possible. It has the special advantage, unlike skin, of being able to survive for long periods in vitro. In this paper we compare the model morphologically with skin and review some aspects of the biosynthetic output of cells in the tissue equivalent with that of monoiayered cells. Finally we illustrate in a pharmacological study that the model can be used to provide new information that in vivo studies or monolayer cell studies cannot yield.

[1]  B. Nusgens,et al.  Collagen biosynthesis by cells in a tissue equivalent matrix in vitro. , 1984, Collagen and related research.

[2]  E. Bell,et al.  Prolylhydroxylase activation in IMR 90 fibroblasts: State of differentiation rather than population doubling level determines requirements for enzyme activation , 1984, Mechanisms of Ageing and Development.

[3]  L. Dubertret,et al.  The contractility of fibroblasts in a collagen lattice is reduced by corticosteroids. , 1984, The Journal of investigative dermatology.

[4]  E Bell,et al.  The reconstitution of living skin. , 1983, The Journal of investigative dermatology.

[5]  L. Dubertret,et al.  Endogenous peroxidases in normal human dermis: a marker of fibroblast differentiation. , 1983, The Journal of investigative dermatology.

[6]  L. Dubertret,et al.  Neutrophil studies in psoriatics: in vivo migration, phagocytosis and bacterial killing. , 1982, The Journal of investigative dermatology.

[7]  L. Verbruggen,et al.  Glucocorticoids alter the ratio of type III type I collagen synthesis by mouse dermal fibroblasts. , 1982, Biochemical pharmacology.

[8]  B. Hull,et al.  Regulation of proliferation of fibroblasts of low and high population doubling levels grown in collagen lattices , 1981, Mechanisms of Ageing and Development.

[9]  E Bell,et al.  Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. , 1981, Science.

[10]  B. Hull,et al.  Development and Use of a Living Skin Equivalent , 1981, Plastic and reconstructive surgery.

[11]  S. Pinnell,et al.  Procollagen I synthesis in human skin fibroblasts: effect on culture conditions on biosynthesis. , 1980, The Journal of investigative dermatology.

[12]  H. Saarni,et al.  Effect of five anti‐inflammatory steroids on collagen and glycoaminoglycan synthessis in vitro , 1980, The British journal of dermatology.

[13]  G. Priestley,et al.  Effects of corticosteroids on the proliferation of normal and abnormal human connective tissue cells , 1980, The British journal of dermatology.

[14]  E Bell,et al.  Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. C. van der Leun,et al.  Suction blisters and dermal-epidermal adherence. , 1968, The Journal of investigative dermatology.